ANNOUNCEMENTS
| Announcement under Regulation 30 (LODR)-Change in Management |
| 27/11/2023| bse |
| Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 27/11/2023| bse |
| Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 23/08/2023| bse |
| Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 21/08/2023| bse |
| Announcement under Regulation 30 (LODR)-Change in Management |
| 21/08/2023| bse |
| Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 08/08/2023| bse |
| Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 08/08/2023| bse |
| Announcement under Regulation 30 (LODR)-Investor Presentation |
| 04/08/2023| bse |
| Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| 04/08/2023| bse |
| Unaudited Financial Results For The Quarter Ended 30.06.2023 |
| 04/08/2023| bse |
| Board Meeting Outcome for Outcome Of Board Meeting |
| 04/08/2023| bse |
| Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 29/07/2023| bse |
| Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 24/07/2023| bse |
| Clarification On Movement In Volume |
| 22/07/2023| bse |
| Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 21/07/2023| bse |
| Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 21/07/2023| bse |
| Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter Ended 30Th June 2023 |
| 21/07/2023| bse |
| Clarification sought from Alembic Pharmaceuticals Ltd |
| 21/07/2023| bse |
| Announcement under Regulation 30 (LODR)-Updates on Acquisition |
| 20/07/2023| bse |
| Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
| 20/07/2023| bse |
Load more
